e-learning
resources
ERJ
2002
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Combined treatment with acetazolamide and medroxyprogesterone in chronic obstructive pulmonary disease patients
Wagenaar M., Je Vos P., Heijdra Y.F., Teppema L.J., Folgering H.T.M.
Source:
Eur Respir J 2002; 20: 1130-1137
Journal Issue:
November
Disease area:
Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Wagenaar M., Je Vos P., Heijdra Y.F., Teppema L.J., Folgering H.T.M.. Combined treatment with acetazolamide and medroxyprogesterone in chronic obstructive pulmonary disease patients. Eur Respir J 2002; 20: 1130-1137
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Efficacy of lasolvan in the treatment of patients with chronic obstructive pulmonary disease
Source: Annual Congress 2009 - Drug effects in COPD
Year: 2009
Acute effects of sildenafil in chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2008 - Pulmonary hypertension I
Year: 2008
Fenspiride efficacy in the treatment of chronic obstructive pulmonary disease
Source: International Congress 2017 – Novel mechanisms and treatments for COPD
Year: 2017
Influence of bronchodilators on pulmonary hypertension in patients with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2003; 22: Suppl. 45, 427s
Year: 2003
Inferon administration to patients with chronic obstructive pulmonary disease
Source: Annual Congress 2009 - Pathological remodelling in chronic lung disease: from epithelial-mesenchymal transition to cellular activation
Year: 2009
Bronchodilatory effects of formoterol in patients with chronic obstructive pulmonary disease (COPD) are not influenced by concomitant corticosteroid use
Source: Eur Respir J 2001; 18: Suppl. 33, 514s
Year: 2001
Chronic thromboembolic pulmonary hypertension complicating long-term cyproterone acetate therapy
Source: Eur Respir Rev 2014; 23:260-263
Year: 2014
The effect of short-acting beta-two-agonist on pulmonary rehabilitation in chronic obstructive pulmonary disease
Source: Annual Congress 2009 - Pulmonary rehabilitation: extending the scope and benefit of rehabilitation for patients with chronic respiratory disease
Year: 2009
Effects of inhaled Iloprost on hemodynamics in chronic obstructive pulmonary disease
Source: Eur Respir J 2002; 20: Suppl. 38, 27s
Year: 2002
Modern treatment of chronic obstructive pulmonary disease
Source: Eur Respir J 2001; 18: 60S-66S
Year: 2001
Effect of systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease
Source: Eur Respir J 2006; 28: Suppl. 50, 624s
Year: 2006
The efficacy of formoterol in patients with chronic obstructive pulmonary disease (COPD) is not influenced by concomitant corticosteroid use
Source: Eur Respir J 2001; 18: Suppl. 33, 515s
Year: 2001
Pulmonary hypertension in COPD
Source: Eur Respir J 2008; 32: 1371-1385
Year: 2008
Principles of diuretic therapy of oedema syndrome in chronic obstructive pulmonary disease patients
Source: Eur Respir J 2006; 28: Suppl. 50, 626s
Year: 2006
Bosentan and pulmonary hypertension in patients affected by chronic obstructive pulmonary disease
Source: Annual Congress 2009 - Pulmonary circulation I
Year: 2009
Use of metoprolol succinate in patients with cardiovascular diseases associated with asthma or chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2006; 28: Suppl. 50, 502s
Year: 2006
Short-term systemic steroid therapy in chronic obstructive pulmonary disease patients with acute respiratory failure
Source: Respiratory Failure and Mechanical Ventilation Conference 2020
Year: 2020
Influence of bronchodilators on pulmonary hypertension (PH) in patients with moderate and severe chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2005; 26: Suppl. 49, 310s
Year: 2005
Maintenance therapy with budesonide and formoterol in chronic obstructive pulmonary disease
Source: Eur Respir J 2004; 24: 1075
Year: 2004
Conclusion: treatment of pulmonary hypertension in COPD patients
Source: Annual Congress 2005 - COPD - pulmonary haemodynamics and gas exchange
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept